Researchers conducted a retrospective study of data from the 2013 Nationwide Readmissions Database. They examined patients with a primary diagnosis of C. diff and rehospitalization within 30 days.
Of 38,409 patients admitted to a hospital with a primary diagnosis of C. diff, 21 percent were readmitted within 30 days, which represents one-in-five C. diff patients. Of those readmitted within 30 days, 27 percent were readmitted with a primary diagnosis of C. diff. Infections accounted for 47 percent of all readmissions.
The following factors increased a patient’s likelihood of being readmitted with C. diff:
• Female sex (12 percent)
• Anemia/coagulation defects (13 percent)
• Renal failure/electrolyte abnormalities (15 percent)
• Discharge to home (36 percent)
More articles on healthcare quality:
California reports spike in flu deaths despite milder flu season
Researchers pinpoint mechanism that makes bacteria resistant to antibiotics
Congo’s Ebola outbreak hits 840 cases: 4 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
